Details Basic Details Date Sunday, August 25, 2019 Type Presentation Medical Product allopurinol febuxostat Materials Characteristics of Febuxostat and Allopurinol Initiators and Utilization Patterns in Real-World Settings Additional Information Information Host 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management Related Assessment(s) Abstracts of the 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Pennsylvania Convention Center, Philadelphia, PA, USA, August 24‐28, 2019 Sentinel Drug Study: Uloric (febuxostat) & Duration of Use and User Characteristics Characteristics of Gout Patients and Use of Urate-Lowering Therapies Contributors Presenter(s) Marie Bradley